Biotech Launches 10% On Mixed Results For Its Top Drug
Biotech Launches 10% On Mixed Results For Its Top Drug
6 months ago
investors.com
Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 b…
3 weeks ago
yahoo.com
EMERALD Trial Recruiting in UK & Spain for End-Stage Liver Disease | Resolution Therapeutics posted on the topic | LinkedIn
EMERALD Trial Recruiting in UK & Spain for End-Stage Liver Diseas…
10.9K views2 months ago
linkedin.com
Prime Therapeutics expands Sempre Health partnership to rein in drug costs
Prime Therapeutics expands Sempre Health partnership to rein …
6 months ago
healthcarefinancenews.com
Mallinckrodt completes spin-off of Par Health, introduces Keenova Therapeutics
Mallinckrodt completes spin-off of Par Health, introduces Keenova T…
6 months ago
marketscreener.com
Opko Health, Inc. completed the acquisition of Transition Therapeutics Inc. from Oracle Investment Management, Inc., Schuler Family Trust, Schuler Family Foundation, Endowment Arm and others.
Opko Health, Inc. completed the acquisition of Transition Therapeu…
Aug 30, 2016
marketscreener.com
Kelonia Therapeutics presents promising CAR-T data at ASH 2025 | BiotechTV posted on the topic | LinkedIn
Kelonia Therapeutics presents promising CAR-T data at ASH 202…
8 views5 months ago
linkedin.com
0:47
Lilly’s $7 billion bet on next-gen cancer therapy
3 weeks ago
MSNDailymotion
2:58
Health care leaders' letter to the FDA: Concerns about approvals f…
5 months ago
MSNCNBC
0:17
Menopause changes the conversation around hormones. D…
23.6K views3 months ago
FacebookReturn to Health Therapeutics
23:19
What's the future of organ transplantation?
Jul 14, 2022
CNN
2:22
Horizon Therapeutics CEO on its record 2020 results
Feb 24, 2021
CNBC
Menarini Group et Stemline Therapeutics, Inc. présentent de n…
Dec 8, 2023
zonebourse.com
U.S. FDA approves Mirati's lung cancer drug
Dec 12, 2022
marketscreener.com
0:20
Emerald Labs Leaky Gut Health - Digestive Support Supplement wit…
100 viewsApr 11, 2023
amazon
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
2 months ago
wsj.com
3:08
Watch CNBC's interview with Horizon Therapeutics CEO Tim W…
Dec 16, 2019
CNBC
3:50
Horizon Therapeutics CEO on demand for company's eye diseas…
May 12, 2020
CNBC
2:56
Horizon Therapeutics in preliminary sale talks with Amgen, Sanofi, J&J
Nov 30, 2022
CNBC
7:42
Sorrento Therapeutics CEO: Start of human trials for our coronavirus d…
Jun 9, 2020
CNBC
Health Care Roundup: Market Talk
3 months ago
WSJ
Health Care Roundup: Market Talk
3 months ago
WSJ
5:00
Inside the production pipeline for new drugs to combat heart failure
10 months ago
MSNFox Business
Prescient advances cancer drug to unlock value
9 months ago
theaustralian.com.au
8:30
Nottingham is investigating a first-in-class cell treatment to help pati…
113 views2 months ago
YouTubeNottingham Clinical Research
1:20
We are Emerald Clinical Trials
35 views1 month ago
VimeoEmerald Clinical Trials
12:04
Cardiol Therapeutics (CRDL) CEO David Elsley on Breakthrough Hea…
2 weeks ago
YouTubeEllis Martin
15:18
Plus Therapeutics CEO Marc Hedrick, MD on Reobyc, CNside, a…
5.2K views3 weeks ago
YouTubeBoardroom Exclusives
3:00
Top 5 Longevity News Stories for this Week!
10.2K views1 month ago
YouTubePhilipp Karner
1:07
Medicus Pharma Submits Phase 2 Study Design for Teverelix in Pros…
11.9K views1 month ago
YouTubeNew to The Street TV
See more videos
Static thumbnail place holder